The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies. Organized by the Biotechnology Innovation Organization (BIO), this annual event provides a forum where institutional investors, industry analysts, and senior biotechnology executives can shape the future investment landscape of the biotechnology industry.
The conference covers a broad range of topics, including issue-oriented plenary sessions and discussions focused on hot therapeutic areas and key business issues. Attendees can gain insights during sessions on therapeutic advancements, market outlook, and policy priorities. Additionally, senior-level company executives present their company’s pipeline, R&D activities, business objectives, and investment goals during company presentations.
Practical details of the event include networking opportunities immediately following the day's programs, allowing attendees to meet new partners and reinforce industry relationships. The conference also features the BIO Partnering™ system, a trusted and efficient way to schedule meetings and make connections in the biotech and pharma industry.
The BIO CEO & Investor Conference is ideal for C-level biotech and biopharma executives, institutional investors, venture capitalists, and private equity investors. With 43% of attendees working in biopharma and 75% holding CEO or C-suite positions, the event offers a collaborative forum to learn and exchange ideas about innovation in the biopharma ecosystem.
Speakers(112)
Abhijit Bhatia
Chief Operating Officer at Rakuten Medical
Adam Bruce
CEO at Abarceo Pharma AB
Alethia Young
Chief Financial Officer at Bicycle Therapeutics
Andrew Cittadine
Chief Operating Officer at Monopar Therapeutics
Andrew Lam
Managing Director, Head of Biotech Private Equity at Ally Bridge Group
Anna Abram
Senior Advisor, Health Care Policy and Legislation at Akin
Bigyan Bista
SVP, Business Strategy & Development at Enveda
Boobalan Pachaiyappan
Managing Director, Senior Biotech Analyst at Roth Capital Partners
Bridget Baldwin
Seek Labs
Brienne Kugler
Senior Vice President, Research & Investments at Royalty Pharma
Chris Chen
Partner, Strategic Investment Fund at Gates Foundation
Chris Garabedian
Venture Fund Manager at Perceptive Advisors
Chris Hoyt
CEO at KeifeRx
Christopher Moore
Ananda Scientific Inc
Conor Cullinane
President, CEO at Pirouette Medical Inc.
Daniel Forman
Partner, Capital Markets & Securities at Lowenstein Sandler LLP
Daniel Schmitt
President & Chief Executive Officer at Actuate Therapeutics
David Bearss
CEO at Halia Therapeutics
David Craig
President and CEO at Sarcomatrix Therapeutics Corp
David Dodd
Chairman & CEO at GeoVax Labs, Inc.
David Mazzo
President and Chief Executive Officer at Lisata Therapeutics
Deirdre De Steno
Senior Vice President, Head of Commercial at Owkin
Deog Joong Kim
CEO at NurrOn Pharmaceuticals, INC
Drew Armstrong
Executive Editor at Endpoints News
Dror Bashan
President, CEO at Protalix Biotherapeutics
Elaine Cheung
Chief Business Officer at Moonwalk Biosciences
Eric Joseph
Biotech Analyst at JP Morgan
Evan Matlin
Partner at MTS Health Partners LP
Everhardus Kueppers
CEO at BOOST Pharma ApS
Gaby Morales-Rivera
Partner at Goodwin
Gene Mack
President and Chief Executive Officer at Gain Therapeutics
Greg Gierer
Principal at Health Management Associates
Gregoire Chevalier
CEO at Atopia Therapeutics
Haining Huang
CEO at Cytimm Therapeutics
Hans Keirstead
Chairman & CEO at AiVita Biomedical, Inc.
Harvey Homan
CEO at MetasTx, LLC
Hendrik Liebers
Chairman at Origenis Gmbh
Ian Frost
ICR
Indu Javeri
President & CEO at CuriRx, Inc
Isan Chen
Co-founder, President and Chief Executive Officer at MBrace Therapeutics, Inc.
Jacob Bell
Senior Reporter at BioPharma Dive
James Carroll
President and CEO at RNA NanoBiotics
James Helliwell
CEO at Eupraxia Pharmaceuticals
James Lovgren
Chief Executive Officer & Co-Founder at Aspiro Therapeutics
Jared Bauer
CEO & Co-Founder at Seek Labs
Jay Backstrom
President & CEO at Scholar Rock
Jay Junkeun Chang
Founder & BOD Chairman at Supernova Bio
Jeff Margolis
Senior Vice President, Chief Financial Officer, Treasurer, Secretary at Endeavourrx LLC
Jeffrey Cleland
Chairman, CEO & President at Ashvattha Therapeutics, Inc.
Jeffrey Finer
CEO and Co-founder at Septerna
Jenny Maharjan
Business Manager at Ziphius LLC
Jerry McLaughlin
CEO at Life Biosciences
Jing-Zhou Hou
Founder and CMO at SirnaMed Therapeutics Inc.
Joe Beggs
CEO at GenAssist, Inc.
John Butler
Chief Executive Officer at Akebia Therapeutics
John Climaco
Chief Executive Officer at CNS Pharmaceuticals, Inc.
John Maraganore
Co-Founder & Executive Chair at City Therapeutics
Jonathan Kaufman
Chief Executive Officer, Chairman and President at Lipella Pharmaceuticals Inc.
Jonathan Kil
CEO at Sound Pharmaceuticals, Inc.
Jonathan Norris
Managing Director at HSBC Innovation
Joseph Conahan
Partner, Co-Chair, Mergers and Acquisitions Practice at WilmerHale
Joshua Gordon
Professor and Chair, Department of Psychiatry, Vagelos College of Physicians and Surgeons at Columbia University, Executive Director, New York State Psychiatric Institute
Karen Brunke
Acting CEO at Magdalena Biosciences
Kate Walsh
Managing Director, Life Science and Healthcare at HSBC Bank USA
Ken Kramer
Vice President and Head of Medical Affairs, Neuropsychiatry Therapeutic Area at BMS
Kent Hawryluk
President & CEO at MBX Biosciences
Laxminarayan Bhat
CEO at Reviva Pharmaceuticals Inc
Leonard Mazur
Chief Executive Officer at Citius Pharmaceuticals
Lindsay Androski
President and CEO at Roivant Social Ventures
Lisa DeFrancesco
Lexicon Pharmaceuticals
Lisa DeScenza
LaVoieHealthScience
Lucas de Breed
Director, Investments - BrightEdge at American Cancer Society
Mercedes Carrasco
Akebia Therapeutics
Michael Foley
Chief Executive Officer at Excelsior Sciences
Michael Yee
Managing Director at Jefferies
Mike Exton
CEO and Director at Lexicon Pharmaceuticals
Mike Gaffney
CEO at Cellphire Therapeutics, Inc
Motti Farbstein
CEO at Can-Fite BioPharma, Ltd.
Nauman Shah
Global Head of Business Development at Johnson & Johnson Innovative Medicine
Neal Koller
CEO at Alphyn Biologics
Nolan Townsend
CEO at Lexeo Therapeutics
Patrick Anquetil
CEO at Portal Instruments
Paul Jaminet
CEO at Angiex Inc.
Pete Norman
Senior Vice President, Policy and Government Relations at Alkermes, Inc.
Puneet Arora
Chief Medical Officer at Skye Bioscience
Rachel Humphrey
Founding Chief Executive Officer at Normunity
Rakhee Ganti
Founder and CEO at Dimer Pharmaceuticals
Raven Lin
CEO at Pilatus Biosciences
Remy Brim
Principal, Health Care Practice Head at BGR Government Affairs, LLC
Ricardo Vilanova
Partner, AI and Intelligent Automation at Ernst & Young, LLP
Riccardo Canevari
CEO at Radiopharm Theranostics
Richard Duke
President at TrAMPoline Pharma, Inc.
Richard Kornbluth
President & Chief Scientific Officer at Multimeric Biotherapeutics, Inc.
Robert Brooks
Chief Executive Officer at Radiance Biopharma
Ron Liu
Chairman and CEO at Bostal LLC
Ronald Li
CEO at Medera
Sabrina Johnson
President and CEO at Dare9 Bioscience
Samuel Bjork
Partner at Digitalis Ventures
Sandeep Gupta
CEO at Leukogene Therapeutics Inc
Sara Nayeem
Executive Vice President, Investments at Enavate Sciences
Seah Lim
Chief Executive Officer at Medicovestor, Inc
Seth Lederman
Chief Executive Officer at Tonix Pharmaceuticals Holding Corp.
Simone Fishburn
Editor in Chief at BioCentury
Srinivas Rao
Co-founder and CEO at atai Life Sciences
Sulagna Bhattacharya
CEO at Nanoscope Therapeutics
Thomas Hoffmann
Head of Institutional Equities & Corporate Access at H.C. Wainwright & Co., LLC
Tony DiTonno
CEO at Dignify Therapeutics
Wendy Guy
Processa Pharmaceuticals, Inc.
Wenqin Hu
Regor Therapeutics
William Annett
CEO at Sustained Therapeutics
William Ho
President, CEO, and Co-founder at IN8bio
Yuanyuan Jin
Co-Founder & COO at Bound Therapeutics
Event Details
- Date
- February 10-11, 2025
- 2 days
- Location
- 🇺🇸 New York, United States
- Audience
- C-level biotech and biopharma executives, institutional investors, venture capitalists, private equity investors